ResearcherThe Cancer Institute HospitalActive in the last 2 years

Yusuke Kazami

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5050330429. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 23

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 3 papers

Papers 4

Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futile pancreatectomy. Co-author DOI 10.1016/j.hpb.2025.12.021 ↗
Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. Co-author DOI 10.1038/s41416-025-03308-7 ↗
Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? Co-author DOI 10.1245/s10434-025-18511-2 ↗
Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemotherapy era. Co-author DOI 10.1016/j.hpb.2023.05.366 ↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kiyoshi Hasegawa · 3 shared papers, 2026 · strength 0.75
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2 ↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Sho Kiritani · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2 ↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
Satoru Abe · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2 ↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
Takeshi Takamoto · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2 ↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
Tatsunori Suzuki · 2 shared papers, 2026 · strength 0.46
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Mitsuhiro Fujishiro · 2 shared papers, 2026 · strength 0.46
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Yosuke Inoue · 2 shared papers, 2023–2026 · strength 0.40
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
- Paper Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemo… DOI 10.1016/j.hpb.2023.05.366 ↗
Yu Takahashi · 2 shared papers, 2023–2026 · strength 0.40
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
- Paper Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemo… DOI 10.1016/j.hpb.2023.05.366 ↗
Kazunaga Ishigaki · 1 shared paper, 2026 · strength 0.26
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
Naminatsu Takahara · 1 shared paper, 2026 · strength 0.26
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021 ↗
Manabu Takamatsu · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Tsuyoshi Takeda · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Tsuyoshi Hamada · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Minoru Kitago · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Yohei Masugi · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Sho Uemura · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Yosuke Uematsu · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Yousuke Nakai · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Naoki Sasahira · 1 shared paper, 2026 · strength 0.21
- Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7 ↗
Yoshihiro Ono · 1 shared paper, 2023 · strength 0.19
- Paper Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemo… DOI 10.1016/j.hpb.2023.05.366 ↗
Atsushi Oba · 1 shared paper, 2023 · strength 0.19
- Paper Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemo… DOI 10.1016/j.hpb.2023.05.366 ↗
Hiromichi Ito · 1 shared paper, 2023 · strength 0.19
- Paper Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemo… DOI 10.1016/j.hpb.2023.05.366 ↗
Akio Saiura · 1 shared paper, 2023 · strength 0.19
- Paper Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemo… DOI 10.1016/j.hpb.2023.05.366 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.